Moxalactam therapy of infections caused by cephalothin-resistant bacteria: influence of serum inhibitory activity on clinical response and acquisition of antibiotic resistance duri...

Por Platt, R, Ehrlich, S L, Afarian, J, O'Brien, T F, Pennington, J E, Kass, E H
Publicado em 1981

Single-dose pharmacokinetics of 3-O-demethylfortimicin A in humans after intravenous and intramuscular administration.

Por Sennello, L T, Wilson, D S, Afarian, J, Holtam, L S, Norman, G, Rollins, D E, Tolman, K G
Publicado em 1986